3d Printed Drugs Market Scope And Analysis

Report Code : TIPRE00010199
Category : Life Sciences

No. of Pages : 150

Buy Now

3D 인쇄 약물 시장 분석, 성장 및 2031년까지의 범위

Buy Now

3D Printed Drugs Market Report Scope

보고서 속성	세부
2023년 시장 규모	3358만 달러
2031년까지 시장 규모	8308만 달러
글로벌 CAGR (2023-2031)	9.6%
역사적 데이터	2021-2022
예측 기간	2024-2031
다루는 세그먼트	투여 형태별 정제 캡슐 다중 약물 임플란트 나노입자 솔루션 기술로 잉크젯 인쇄 직접 쓰기 지퍼 복용량 열전사 잉크젯 인쇄 용융 증착 모델링 파우더 베드 프린팅 입체석판 인쇄 반고체 압출
포함된 지역 및 국가	북아메리카 우리를 캐나다 멕시코 유럽 영국 독일 프랑스 러시아 제국 이탈리아 유럽의 나머지 지역 아시아 태평양 중국 인도 일본 호주 아시아 태평양의 나머지 지역 남미 및 중미 브라질 아르헨티나 남미와 중미의 나머지 지역 중동 및 아프리카 남아프리카 공화국 사우디 아라비아 아랍에미리트 중동 및 아프리카의 나머지 지역
시장 선도 기업 및 주요 회사 프로필	APRECIA PHARMACEUTICALS, LLC(아프레시아 파마슈티컬스, 유한회사) 파브알엑스 주식회사 사이클 제약 글락소스미스클라인 주식회사. 아스트라제네카 트바스타 머크 KGGA

3D 인쇄 약물 시장 참여자 밀도: 비즈니스 역학에 미치는 영향 이해

The 3D Printed Drugs Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

Major Companies operating in the 3D Printed Drugs Market are:

APRECIA PHARMACEUTICALS, LLC
FabRx LTD
Cycle Pharmaceuticals
GLAXOSMITHKLINE PLC.
ASTRAZENECA
Tvasta

Disclaimer

: The companies listed above are not ranked in any particular order.

Get the 3D Printed Drugs Market top key players overview

(KEEP THIS KEYWORD HERE FOR SHYAM)

“

DO NOT ADD ANY TABLE HERE

”

3D Printed Drugs Market News and Recent Developments

The 3D printed drugs market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for innovations, business expansion, and strategies:

In October, 2023, Finnish healthtech company CurifyLabs has announced the launch first in the world GMP (good manufacturing practice) produced Pharma Inks for 3D printable medicines. CurifyLabs’ Pharma Kit, including automated 3D printing technology and printable pharmaceutical inks, enables wider adoption of personalised medicine, resulting in better future care for patients with different needs according to the company. (Source: CurifyLabs, Press Release)
In September 2023, LSMU (Lithuanian University of Health Sciences)launches the first validated pharmaceutical 3D Printer. The new device sets a new course for innovation development in pharmaceutical technologies. It allows to produce personalised medicine tailored to each individual patient, increase the efficacy of medicines by combining several substances in a single tablet and reducing the side effects of medicines. (Source: LSMU, Press Release)

3D Printed Drugs Market Report Coverage and Deliverables

The “3D Printed Drugs Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering the following areas:

3D Printed Drugs Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
Market dynamics such as drivers, restraints, and key opportunities
3D Printed Drugs Market trends
Detailed PEST and SWOT analysis
3D Printed Drugs market analysis covering key market trends, Global and regional framework, major players, regulations, and recent market developments.
3D 프린팅 약물시장 집중도, 히트맵 분석, 주요 업체 및 최근 개발 사항을 다루는 산업 환경 및 경쟁 분석입니다.
자세한 회사 프로필